All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

18

Reset

18 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • CHO Cellrecombinant zoster vaccine, Recombinant Respiratory Syncytial Virus VaccinePhase 39 trials

    MAXVAX Biotechnology Limited Liability Company · Herpes Zoster, Respiratory Syncytial Virus (RSV), Herpes Zoster (HZ)

  • RSVpreFRESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE, PF-06928316Phase 38 trials

    Pfizer · Respiratory Syncytial Virus (RSV), Lower Respiratory Tract Illness, Adult

  • RSVpreF VaccinePhase 33 trials

    Pfizer · Respiratory Syncytial Virus, Respiratory Syncytial Virus (RSV)

  • GSK · Respiratory Syncytial Virus Infections

  • RSVPreF3 OA vaccinePhase 32 trials

    GSK · Respiratory Syncytial Virus Infections

  • su vaccineRZVPhase 32 trials

    GSK · Herpes Zoster, Respiratory Syncytial Virus (RSV)

  • TNM001Phase 32 trials

    Zhuhai Trinomab Pharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections

  • zelicapavirPhase 32 trials

    Enanta Pharmaceuticals, Inc · RSV, RSV Infection, Respiratory Syncytial Virus (RSV)

  • ZiresovirAK0529Phase 32 trials

    Shanghai Ark Biopharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections, Respiratory Synctial Virus Infections

  • LYB005Phase 31 trial

    Guangzhou Patronus Biotech Co., Ltd. · Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection, RSV Vaccine

  • GSK · Cardiovascular Disease, Respiratory Syncytial Virus Infections

  • hMPV vaccinePhase 22 trials

    Sanofi · Human Metapneumovirus Immunization, Respiratory Syncytial Virus Immunization, Healthy Volunteers

  • RSV vaccine candidatePhase 22 trials

    Sanofi · Respiratory Syncytial Virus Infection, Healthy Volunteers, Respiratory Syncytial Virus Immunization

  • ABO1105Phase 21 trial

    Suzhou Abogen Biosciences Co., Ltd. · Respiratory Syncytial Virus

  • AZD6489Phase 21 trial

    AstraZeneca · RSV Respiratory Syncytial Virus

  • BLB-201PIV5-vectored RSV VaccinePhase 21 trial

    Blue Lake Biotechnology Inc. · Respiratory Syncytial Virus Infections

  • SCTV02Phase 21 trial

    Sinocelltech Ltd. · Respiratory Syncytial Virus

  • SYH2066Phase 21 trial

    CSPC Ouyi Pharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.